Insurance Startup Turtlemint Nears Unicorn Status With New Round
(Bloomberg) -- India's Turtlemint raised $120 million in a round led by Amansa Capital, Jungle Ventures and Nexus Venture Partners, gaining funds for expansion as a swath of technology-driven companies race to sell insurance policies in an under-penetrated market.
Vitruvian Partners, Marshall Wace and early Turtlemint investors also participated in the Series E round. The Mumbai-based company reached a “slightly less than unicorn valuation” in the deal, co-founder Dhirendra Mahyavanshi said Friday, referring to the tech industry's term for startups valued at $1 billion or more.
The Sequoia Capital-backed startup will use the funds to expand to new geographies, particularly the Middle East and Southeast Asia, as well as to invest in its distribution, underwriting and claims technology. Turtlemint offers online training to insurance agents in smaller cities and towns, helping them to sell coverage to consumers. Rivals sell insurance directly to customers, including Paytm, Policybazaar and the Amazon.com Inc.-backed Acko.
“Insurance is a knowledge-based product best validated by buying through experts,” Mahyavanshi, 43, said on a video call.
Turtlemint has tapped more than 160,000 insurance advisers, helping it scale fast without significant spending. Nearly three-quarters of the startup's business comes from outside the country's biggest 30 cities and the company offers its service in six major Indian languages, including Hindi, Kannada and Tamil. India's insurance penetration was about 4.2% in the year ending March 2021, according to the Ministry of Commerce's India Brand Equity Foundation.
Mahyavanshi, a 10-year veteran of the insurance industry, co-founded the startup in 2015 with Anand Prabhudesai. It sells about 12,000 policies daily, including health, life, vehicle and personal accident policies, and has reached an annual revenue run rate of $380 million, he said. It also offers its insurance training and selling platform to banks and insurers as subscription software.
©2022 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
